Sage Therapeutics Inc (DELISTED) (SAGE:DL)
8.68
0.00 (0.00%)
USD |
NASDAQ |
Aug 04, 16:00
Sage Therapeutics Total Assets (Quarterly): 422.92M for June 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 1.420B |
| Biogen, Inc. | 29.21B |
| Eli Lilly & Co. | 114.94B |
| Sarepta Therapeutics, Inc. | 3.493B |
| IGM Biosciences, Inc. (DELISTED) | 106.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 54.18M |
| Shareholders Equity (Quarterly) | 368.74M |
| Current Ratio | 9.164 |